|
TTK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.18890000020156E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.239450E-04 |
| Normal-vs-Stage2 |
2.584500E-03 |
| Normal-vs-Stage3 |
2.67710000001475E-06 |
| Normal-vs-Stage4 |
1.80824000000079E-05 |
| Stage1-vs-Stage2 |
7.217600E-01 |
| Stage1-vs-Stage3 |
2.282200E-02 |
| Stage1-vs-Stage4 |
1.335290E-03 |
| Stage2-vs-Stage3 |
2.023800E-01 |
| Stage2-vs-Stage4 |
3.060400E-03 |
| Stage3-vs-Stage4 |
1.473910E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.88070000017859E-07 |
| Normal-vs-AfricanAmerican |
4.313900E-02 |
| Normal-vs-Asian |
2.118200E-02 |
| Caucasian-vs-AfricanAmerican |
8.124200E-03 |
| Caucasian-vs-Asian |
7.456800E-01 |
| AfricanAmerican-vs-Asian |
1.413650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.10010000004191E-07 |
| Normal-vs-Female |
1.603760E-04 |
| Male-vs-Female |
1.146550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.321300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.73320999999893E-05 |
| Normal-vs-Age(61-80Yrs) |
2.45279999999681E-06 |
| Normal-vs-Age(81-100Yrs) |
4.693700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.731800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.707800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.340400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.259200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.139700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.236700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.708440E-01 |
| Normal-vs-Grade 2 |
8.14860000000195E-05 |
| Normal-vs-Grade 3 |
1.23029999998803E-06 |
| Normal-vs-Grade 4 |
3.86070000000238E-05 |
| Grade 1-vs-Grade 2 |
1.020610E-03 |
| Grade 1-vs-Grade 3 |
1.79431999999258E-05 |
| Grade 1-vs-Grade 4 |
1.439660E-04 |
| Grade 2-vs-Grade 3 |
1.370360E-01 |
| Grade 2-vs-Grade 4 |
2.263900E-03 |
| Grade 3-vs-Grade 4 |
6.480800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.895390E-03 |
| Normal-vs-ccB subtype |
8.16630000288754E-08 |
| ccA subtype-vs-ccB subtype |
2.244000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77310000004649E-06 |
| Normal-vs-N1 |
9.777800E-04 |
| N0-vs-N1 |
6.896100E-03 |
|
|
